The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers

NCT04950530 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: BIKTARVY 50Mg-200Mg-25Mg Tablet

Sponsor

Chelsea and Westminster NHS Foundation Trust